The State Food and Drug Administration issued an announcement on the revision of the instructions for domperidone preparations

icon-192x192.png

Visit the original URL
The State Drug Administration recently decided to revise the contents of the instructions for domperidone preparations (including domperidone tablets, domperidone dispersible tablets, domperidone orally disintegrating tablets, domperidone capsules, domperidone suspension, and domperidone maleate tablets). Among them, the revised prescription of domperidone preparations requires that “precautions” should include: children under 12 years old (especially infants), adolescents and adults weighing less than 35 kg should be used with caution, and adverse reactions should be closely monitored during medication. Domperidone is not suitable for children under 12 years old (especially infants), adolescents and adults weighing less than 35 kg. (CCTV News)
media coverage

36Kr

This article is reproduced from: https://readhub.cn/topic/8kAMX9ZEUx8
This site is for inclusion only, and the copyright belongs to the original author.